Daratumumab in Treating Transplant-Eligible Patients With Multiple Myeloma

Clinical trial NCT03477539 · COMPLETED

Trial details

NCT number: NCT03477539
Sponsor: Mayo Clinic
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Plasma Cell Myeloma

Start date: 2018-04-09
Primary completion: 2022-05-11
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.